These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1046 related items for PubMed ID: 12434564

  • 1. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A, Fouilloux C, Ortiz S.
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract] [Full Text] [Related]

  • 2. Fluoxetine (prozac) in depresion of adults.
    Kocur J, Rydzynski Z, Duszyk S, Gruszczynski W, Trendak W.
    Homeost Health Dis; 1991; 33(5-6):295. PubMed ID: 18265505
    [No Abstract] [Full Text] [Related]

  • 3. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
    Marchesi C, Ceccherininelli A, Rossi A, Maggini C.
    Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
    Rothschild AJ, Samson JA, Bessette MP, Carter-Campbell JT.
    J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
    [Abstract] [Full Text] [Related]

  • 5. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF, Sayler ME, Koke SC, Pearson DK, Tollefson GD.
    Depress Anxiety; 1997 Sep; 6(1):31-9. PubMed ID: 9394873
    [Abstract] [Full Text] [Related]

  • 6. Adinazolam, diazepam, imipramine, and placebo in major depressive disorder: a controlled study.
    Rickels K, London J, Fox I, Hassman H, Csanalosi I, Weise C.
    Pharmacopsychiatry; 1991 Jul; 24(4):127-31. PubMed ID: 1754608
    [Abstract] [Full Text] [Related]

  • 7. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
    Möller HJ, Kasper S, Müller H, Kissling W, Fuger J, Ruhrmann S.
    Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P, Baker B, Irvine J, Dorian P, McKessok D, Mendlowitz S.
    Depress Anxiety; 1998 Nov; 7(2):69-72. PubMed ID: 9614594
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of trimipramine and fluoxetine on sleep in geriatric depression.
    Wolf R, Dykierek P, Gattaz WF, Maras A, Kohnen R, Dittmann RW, Geuppert M, Riemann D, Berger M.
    Pharmacopsychiatry; 2001 Mar; 34(2):60-5. PubMed ID: 11302565
    [Abstract] [Full Text] [Related]

  • 10. Fluoxetine in depressed patients: a comparison with imipramine.
    Bremner JD.
    J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
    [Abstract] [Full Text] [Related]

  • 11. A new antidepressant agent: amitriptyline-N-oxide.
    Borromei A.
    Adv Biochem Psychopharmacol; 1982 Oct; 32():43-7. PubMed ID: 7046367
    [No Abstract] [Full Text] [Related]

  • 12. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
    Wehmeier PM, Kluge M, Maras A, Riemann D, Berger M, Kohnen R, Dittmann RW, Gattaz WF.
    Pharmacopsychiatry; 2005 Jan; 38(1):13-6. PubMed ID: 15706460
    [Abstract] [Full Text] [Related]

  • 13. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR, Mulder RT, McKenzie JM, Luty SE, Cloninger CR.
    Depress Anxiety; 2004 Jan; 19(3):180-6. PubMed ID: 15129420
    [Abstract] [Full Text] [Related]

  • 14. Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): a double-blind comparison.
    Versiani M, Ontiveros A, Mazzotti G, Ospina J, Dávila J, Mata S, Pacheco A, Plewes J, Tamura R, Palacios M.
    Int Clin Psychopharmacol; 1999 Nov; 14(6):321-7. PubMed ID: 10565798
    [Abstract] [Full Text] [Related]

  • 15. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
    Feighner JP.
    J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204
    [Abstract] [Full Text] [Related]

  • 16. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P, Hardison CD.
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [Abstract] [Full Text] [Related]

  • 17. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders.
    Baca E, Garcia-Garcia M, Porras-Chavarino A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):57-65. PubMed ID: 14687858
    [Abstract] [Full Text] [Related]

  • 18. Antidepressant drug use: differences between psychiatrists and general practitioners. Results from a drug utilization observation study with fluoxetine.
    Dittmann RW, Linden M, Osterheider M, Schaaf B, Ohnmacht U, Weber HJ.
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):28-34. PubMed ID: 9035225
    [Abstract] [Full Text] [Related]

  • 19. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment.
    Hellweg R, Ziegenhorn A, Heuser I, Deuschle M.
    Pharmacopsychiatry; 2008 Mar; 41(2):66-71. PubMed ID: 18311687
    [Abstract] [Full Text] [Related]

  • 20. Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use.
    Wolfersdorf M, Barg T, König F, Leibfarth M, Grünewald I.
    Pharmacopsychiatry; 1995 Mar; 28(2):56-60. PubMed ID: 7624387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.